Wells Fargo’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.62M | Sell |
123,037
-20,728
| -14% | -$1.07M | ﹤0.01% | 2327 |
|
|
2026
Q1 | $7.3M | Buy |
143,765
+18,958
| +15% | +$884K | ﹤0.01% | 2276 |
|
|
2025
Q4 | $3.68M | Buy |
124,807
+12,455
| +11% | +$338K | ﹤0.01% | 2956 |
|
|
2025
Q3 | $2.9M | Buy |
112,352
+16,969
| +18% | +$473K | ﹤0.01% | 3041 |
|
|
2025
Q2 | $2.63M | Buy |
95,383
+10,523
| +12% | +$277K | ﹤0.01% | 2996 |
|
|
2025
Q1 | $2.41M | Sell |
84,860
-420,867
| -83% | -$14.9M | ﹤0.01% | 3026 |
|
|
2024
Q4 | $21M | Buy |
505,727
+185,206
| +58% | +$8.85M | ﹤0.01% | 1317 |
|
|
2024
Q3 | $21.4M | Sell |
320,521
-95,959
| -23% | -$8.81M | ﹤0.01% | 1258 |
|
|
2024
Q2 | $49.5M | Buy |
416,480
+142,980
| +52% | +$18.1M | 0.01% | 778 |
|
|
2024
Q1 | $29.1M | Buy |
273,500
+12,822
| +5% | +$1.29M | 0.01% | 1008 |
|
|
2023
Q4 | $25.9M | Sell |
260,678
-42,533
| -14% | -$3.58M | 0.01% | 1020 |
|
|
2023
Q3 | $31.3M | Sell |
303,211
-14,210
| -4% | -$1.59M | 0.01% | 879 |
|
|
2023
Q2 | $38.6M | Sell |
317,421
-20,138
| -6% | -$2.69M | 0.01% | 804 |
|
|
2023
Q1 | $51.8M | Buy |
337,559
+19,953
| +6% | +$3.29M | 0.01% | 680 |
|
|
2022
Q4 | $57M | Sell |
317,606
-35,437
| -10% | -$5.79M | 0.02% | 627 |
|
|
2022
Q3 | $41.7M | Sell |
353,043
-9,780
| -3% | -$1.48M | 0.01% | 723 |
|
|
2022
Q2 | $51.8M | Sell |
362,823
-66,786
| -16% | -$9.55M | 0.02% | 658 |
|
|
2022
Q1 | $74M | Sell |
429,609
-39,521
| -8% | -$6.65M | 0.02% | 602 |
|
|
2021
Q4 | $119M | Sell |
469,130
-101,312
| -18% | -$29.6M | 0.03% | 429 |
|
|
2021
Q3 | $220M | Buy |
570,442
+195,101
| +52% | +$72M | 0.05% | 383 |
|
|
2021
Q2 | $88.2M | Sell |
375,341
-8,383
| -2% | -$1.5M | 0.02% | 748 |
|
|
2021
Q1 | $50.2M | Sell |
383,724
-33,989
| -8% | -$4.93M | 0.01% | 1046 |
|
|
2020
Q4 | $43.6M | Buy |
417,713
+160,677
| +63% | +$16.3M | 0.01% | 1061 |
|
|
2020
Q3 | $18.2M | Buy |
257,036
+2,460
| +1% | +$172K | 0.01% | 1477 |
|
|
2020
Q2 | $16.3M | Buy |
254,576
+100,760
| +66% | +$5.52M | ﹤0.01% | 1492 |
|
|
2020
Q1 | $4.61M | Buy |
153,816
+54,706
| +55% | +$1.26M | ﹤0.01% | 2297 |
|
|
2019
Q4 | $1.94M | Buy |
99,110
+33,257
| +51% | +$590K | ﹤0.01% | 3368 |
|
|
2019
Q3 | $1.05M | Buy |
65,853
+52,140
| +380% | +$770K | ﹤0.01% | 3802 |
|
|
2019
Q2 | $201K | Buy |
13,713
+709
| +5% | +$15.2K | ﹤0.01% | 4971 |
|
|
2019
Q1 | $265K | Buy |
13,004
+8,266
| +174% | +$153K | ﹤0.01% | 4678 |
|
|
2018
Q4 | $72K | Buy |
+4,738
| New | +$77.9K | ﹤0.01% | 5420 |
|
Other funds holding MRNA
TP
Wells Fargo's MRNA Position: Q2 2026 in Review
Wells Fargo reduced its Moderna (MRNA) stake by 14% in Q2 2026, selling an estimated $1.07M and leaving 123,037 shares worth $8.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.
Wells Fargo first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $220M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Wells Fargo held 123,037 shares of Moderna worth $8.62M as of Q2 2026.
- Wells Fargo sold 20,728 Moderna shares in Q2 2026, an estimated $1.07M.
- Moderna made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2327 holding.
- Wells Fargo first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
- Wells Fargo's Moderna position peaked at $220M in Q3 2021.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.